This is an NIH/NIDCD cooperative agreement for clinical trials treating or preventing communication disorders—hearing, balance, speech, voice, or language. It is for organizations that can run a serious clinical trial requiring FDA oversight, formal efficacy testing, or carrying elevated risk of harm; if you are a small business without clinical trial infrastructure or research capacity, do not bother. The award amount is not published, and the deadline is October 18, 2027.
- Best for
- Universities and academic medical centers running FDA-regulated clinical trials in hearing, balance, speech, voice, or语言, Biotech and medical device companies (including small businesses) testing treatments for communication disorders, Hospitals, health systems, and nonprofits with the clinical trial infrastructure NIDCD requires, Tribal, state, and local government entities with research capacity in communication disorders
- Not for
- Businesses outside healthcare and biotech with no clinical trial capability, Organizations without FDA-regulated trial experience or the capacity to run a cooperative agreement with NIH, Foreign or non-U.S.-based entities
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.